Abstract
Background Observational studies have reported an association between allergic disease and mental health, but a causal relationship has not been established.
Objective To use Mendelian Randomization (MR) to investigate a possible causal relationship between atopic disease and mental health phenotypes.
Methods The observational relationship between allergic disease and mental health was investigated in UK Biobank. The direction of causality was investigated with bidirectional two-sample MR using summary-level data from published genome-wide association studies. A genetic instrument was derived from associated variants for a broad allergic disease phenotype to test for causal relationships with various mental health outcomes. Genetic instruments were also derived for mental health conditions to assess causality in the reverse direction. We also investigated if these relationships were specific to atopic dermatitis (AD), asthma or hay fever.
Results The broad allergic disease phenotype was phenotypically associated with most measures of mental health, but we found little evidence of causality in either direction. However, we did find evidence of genetic liability for bipolar disorder causally influencing hay fever risk (OR=0.94 per doubling odds of bipolar disorder risk; 95%CI=0.90-0.99; P-value=0.02), but evidence of a phenotypic association was weak.
Conclusions Few of the phenotypic associations between allergic disease and mental health were replicated. Any causal effects we detected were considerably attenuated compared to the phenotypic association. This suggests that most co-morbidity observed clinically is unlikely to be causal.
Clinical Implication We found little evidence that genetic predisposition to allergic disease causes mental ill-health, and vice versa, which suggests that intervening to prevent onset of allergic disease is unlikely to directly prevent the onset of mental ill-health.
Key Messages
Mendelian randomization effect estimates suggest that the phenotypic association between allergic disease and mental health is likely to be inflated
Causal analysis was unable to corroborate the phenotypic associations observed between allergic disease and mental health phenotypes
Intervening on an individual’s allergic disease is not likely to directly improve their mental health
Capsule summary Mendelian Randomization suggests that evidence of a causal relationship between allergic disease and mental health phenotypes is weak. It is unlikely that intervening to prevent onset of allergic disease will prevent poor mental health.
- allergic disease
- association
- asthma
- causal
- atopic dermatitis
- hay fever
- Mendelian randomization
- mental health
Competing Interest Statement
LP has received personal fees from Merck for Scientific Input Engagement related to MR methodology. All other authors report no conflicts of interest.
Funding Statement
This research has been conducted using the UK Biobank Resource under Application Number 9142. Details of patient and public involvement in the UK Biobank are available online (http://www.ukbiobank.ac.uk/about-biobank-uk/ and https://www.ukbiobank.ac.uk/wp-content/uploads/2011/07/Summary-EGF-consultation.pdf). No patients were specifically involved in setting the research question or the outcome measures, nor were they involved in developing plans for recruitment, design, or implementation of this study. No patients were asked to advise on interpretation or writing up of results. There are no specific plans to disseminate the results of the research to study participants, but the UK Biobank disseminates key findings from projects on its website.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank is approved by the National Health Service National Research Ethics Service (ref 11/NW/0382; UK Biobank application number 9142).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding AB-A, ND, LP, MRM & HMS work in a research unit funded by the UK Medical Research Council (MC_UU_00011/1, MC_UU_00011/7). LP received funding from the British Skin Foundation (8010 Innovative Project) and the Academy of Medical Sciences Springboard Award, which is supported by the Wellcome Trust, The Government Department for Business, Energy and Industrial Strategy, the Global Challenges Research Fund and the British Heart Foundation [SBF003\1094]. HMS is supported by the European Research Council (Grant ref: 758813 MHINT). This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at the University Hospitals Bristol National Health Service Foundation Trust. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. SJB holds a Wellcome Trust Senior Research Fellowship in Clinical Science (106865/Z/15/Z) and a British Skin Foundation large project grant. NMD is supported by a Norwegian Research Council Grant number 295989. The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests LP has received personal fees from Merck for Scientific Input Engagement related to MR methodology. All other authors report no conflicts of interest.
Data Availability
Data from UK Biobank (as used in observational analyses) are available to researchers on request, subject to a data access fee. The code and datasets used to carry out the MR analyses are available on GitHub (https://github.com/abudu-aggrey/Allergic_Disease_Mental_Health_MR).
https://github.com/abudu-aggrey/Allergic_Disease_Mental_Health_MR
Abbreviations
- AD
- Atopic Dermatitis
- CI
- Confidence interval
- GWAS
- Genome-wide association study
- IVW
- Inverse-variance weighted
- MBE
- Mode-based estimate
- MDD
- Major Depressive Disorder
- MR
- Mendelian Randomization
- OR
- Odds ratio
- SNP
- Single-nucleotide polymorphism